Skip to main content
Top
Published in: Chinese Medicine 1/2020

01-12-2020 | Acupuncture | Research

Efficacy of acupuncture in the prevention and treatment of chemotherapy-induced nausea and vomiting in patients with advanced cancer: a multi-center, single-blind, randomized, sham-controlled clinical research

Authors: Qi-Wei Li, Ming-Wei Yu, Xiao-Min Wang, Guo-Wang Yang, Huan Wang, Chen-Xi Zhang, Na Xue, Wei-Ru Xu, Yi Zhang, Pei-Yu Cheng, Lin Yang, Qi Fu, Zhong Yang

Published in: Chinese Medicine | Issue 1/2020

Login to get access

Abstract

Background

Chemotherapy-induced nausea and vomiting (CINV) is a common and distressing side effect. We conducted this clinical trial to compare the effectiveness of true acupuncture vs. sham acupuncture in controlling chemotherapy-induced nausea and vomiting (CINV) among patients with advanced cancer.

Methods

A total of 134 participants were randomly allocated into true acupuncture (TA) (n = 68) and sham acupuncture (SA) (n = 66) groups. Participants in both groups received acupuncture session twice on the first day of chemotherapy, and once consecutively on the following 4 days. The primary outcome was using the Common Terminology Criteria for Adverse Events (CTCAE) to assess CINV. The secondary outcome measures were the Eastern Cooperative Oncology Group score (ECOG), Simplified Nutritional Appetite Questionnaire (SNAQ), and Hospital Anxiety and Depression scale (HADS).

Results

Compared to the SA group, the TA group didn’t show significant improvement in complete response rates of chemotherapy-induced nausea and vomiting (all P > 0.05). However, the TA group could modestly reduce the severity of nausea (from day-3 to day-21, P < 0.05) or vomiting (from day-4 to day-21, P < 0.05), which is notably superior to the control group. Besides, TA promoted the nutritional status of patients with a significantly higher score comparing to the SA group on day 14 (21.82 vs.20.12, P = 0.003) and day 21 (22.39 vs. 20.43, P = 0.001). No apparent differences were found in anxiety and depression assessment between these groups. Participants in both groups were well tolerant of acupuncture therapy. There was no adverse event occurs in our study.

Conclusion

Acupuncture as an adjunctive approach could alleviate the severity of chemotherapy-induced nausea and vomiting compared to the sham control, even though the effect of acupuncture in preventing CINV occurring is relatively modest.
Appendix
Available only for authorised users
Literature
1.
go back to reference Navari RM, Aapro M. Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. New Engl J Med. 2016;374(14):1356–67.CrossRef Navari RM, Aapro M. Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. New Engl J Med. 2016;374(14):1356–67.CrossRef
2.
go back to reference Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA, et al. Antiemetics: American society of clinical oncology clinical practice guideline update. J Clin Oncol. 2017;35(28):3240–61.CrossRef Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA, et al. Antiemetics: American society of clinical oncology clinical practice guideline update. J Clin Oncol. 2017;35(28):3240–61.CrossRef
3.
go back to reference Hashimoto H, Abe M, Tokuyama O, Mizutani H, Uchitomi Y, Yamaguchi T, et al. Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomized, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2020;21(2):242–9.CrossRef Hashimoto H, Abe M, Tokuyama O, Mizutani H, Uchitomi Y, Yamaguchi T, et al. Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomized, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2020;21(2):242–9.CrossRef
4.
go back to reference Roscoe JA, Heckler CE, Morrow GR, Mohile SG, Dakhil SR, Wade JL, et al. Prevention of delayed nausea: a University of Rochester Cancer Center community clinical oncology program study of patients receiving chemotherapy. J Clin Oncol. 2012;30(27):3389–95.CrossRef Roscoe JA, Heckler CE, Morrow GR, Mohile SG, Dakhil SR, Wade JL, et al. Prevention of delayed nausea: a University of Rochester Cancer Center community clinical oncology program study of patients receiving chemotherapy. J Clin Oncol. 2012;30(27):3389–95.CrossRef
5.
go back to reference Clark-Snow R, Affronti ML, Rittenberg CN. Chemotherapy-induced nausea and vomiting (CINV) and adherence to antiemetic guidelines: results of a survey of oncology nurses. Support Care Cancer. 2018;26(2):557–64.CrossRef Clark-Snow R, Affronti ML, Rittenberg CN. Chemotherapy-induced nausea and vomiting (CINV) and adherence to antiemetic guidelines: results of a survey of oncology nurses. Support Care Cancer. 2018;26(2):557–64.CrossRef
6.
go back to reference Grunberg SM. Obstacles to the implementation of antiemetic guidelines. J Natl Compr Cancer Net. 2009;7(5):601–5.CrossRef Grunberg SM. Obstacles to the implementation of antiemetic guidelines. J Natl Compr Cancer Net. 2009;7(5):601–5.CrossRef
7.
go back to reference Salsman JM, Grunberg SM, Beaumont JL, Rogers M, Paul D, Clayman ML, et al. Communicating about chemotherapy-induced nausea and vomiting: a comparison of patient and provider perspectives. J Nat Compr Cancer Net. 2012;10(2):149–57.CrossRef Salsman JM, Grunberg SM, Beaumont JL, Rogers M, Paul D, Clayman ML, et al. Communicating about chemotherapy-induced nausea and vomiting: a comparison of patient and provider perspectives. J Nat Compr Cancer Net. 2012;10(2):149–57.CrossRef
8.
go back to reference Ng TL, Hutton B, Clemons M. Chemotherapy-induced nausea and vomiting: time for more emphasis on nausea? Oncologist. 2015;20(6):576–83.CrossRef Ng TL, Hutton B, Clemons M. Chemotherapy-induced nausea and vomiting: time for more emphasis on nausea? Oncologist. 2015;20(6):576–83.CrossRef
9.
go back to reference Navari RM, Schwartzberg LS. Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting. Onco Targets Ther. 2018;11:6459–78.CrossRef Navari RM, Schwartzberg LS. Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting. Onco Targets Ther. 2018;11:6459–78.CrossRef
10.
go back to reference Lyman GH, Greenlee H, Bohlke K, Bao T, DeMichele AM, Deng GE, et al. Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline. J Clin Oncol. 2018;36(25):2647–55.CrossRef Lyman GH, Greenlee H, Bohlke K, Bao T, DeMichele AM, Deng GE, et al. Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline. J Clin Oncol. 2018;36(25):2647–55.CrossRef
11.
go back to reference Magnusson M, Hoglund P, Johansson K, Jonsson C, Killander F, Malmstrom P, et al. Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5). Eur J Cancer. 2009;45(14):2488–95.CrossRef Magnusson M, Hoglund P, Johansson K, Jonsson C, Killander F, Malmstrom P, et al. Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5). Eur J Cancer. 2009;45(14):2488–95.CrossRef
12.
go back to reference Rithirangsriroj K, Manchana T, Akkayagorn L. Efficacy of acupuncture in prevention of delayed chemotherapy induced nausea and vomiting in gynecologic cancer patients. Gynecol Oncol. 2015;136(1):82–6.CrossRef Rithirangsriroj K, Manchana T, Akkayagorn L. Efficacy of acupuncture in prevention of delayed chemotherapy induced nausea and vomiting in gynecologic cancer patients. Gynecol Oncol. 2015;136(1):82–6.CrossRef
13.
go back to reference Shen J, Wenger N, Glaspy J, Hays RD, Albert PS, Choi C, et al. Electroacupuncture for control of myeloablative chemotherapy-induced emesis: a randomized controlled trial. JAMA. 2000;284(21):2755–61.CrossRef Shen J, Wenger N, Glaspy J, Hays RD, Albert PS, Choi C, et al. Electroacupuncture for control of myeloablative chemotherapy-induced emesis: a randomized controlled trial. JAMA. 2000;284(21):2755–61.CrossRef
14.
go back to reference Garcia MK, McQuade J, Haddad R, Patel S, Lee R, Yang P, et al. Systematic review of acupuncture in cancer care: a synthesis of the evidence. J Clin Oncol. 2013;31(7):952–60.CrossRef Garcia MK, McQuade J, Haddad R, Patel S, Lee R, Yang P, et al. Systematic review of acupuncture in cancer care: a synthesis of the evidence. J Clin Oncol. 2013;31(7):952–60.CrossRef
15.
go back to reference Murphy JF. Consort 2010 statement on randomised controlled trials. Ir Med J. 2010;103(5):132.PubMed Murphy JF. Consort 2010 statement on randomised controlled trials. Ir Med J. 2010;103(5):132.PubMed
16.
go back to reference MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White A, et al. Revised standards for reporting interventions in clinical trials of acupuncture (STRICTA): extending the CONSORT statement. J Evid Based Med. 2010;3(3):140–55.CrossRef MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White A, et al. Revised standards for reporting interventions in clinical trials of acupuncture (STRICTA): extending the CONSORT statement. J Evid Based Med. 2010;3(3):140–55.CrossRef
17.
go back to reference Ettinger DS, Bierman PJ, Bradbury B, Comish CC, Ellis G, Ignoffo RJ, et al. Antiemesis. J Nat Compr Cancer Net. 2007;5(1):12–33.CrossRef Ettinger DS, Bierman PJ, Bradbury B, Comish CC, Ellis G, Ignoffo RJ, et al. Antiemesis. J Nat Compr Cancer Net. 2007;5(1):12–33.CrossRef
18.
go back to reference Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol. 1982;5(6):649–55.CrossRef Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol. 1982;5(6):649–55.CrossRef
19.
go back to reference Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.CrossRef Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.CrossRef
20.
go back to reference Wilson MM, Thomas DR, Rubenstein LZ, Chibnall JT, Anderson S, Baxi A, et al. Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr. 2005;82(5):1074–81.CrossRef Wilson MM, Thomas DR, Rubenstein LZ, Chibnall JT, Anderson S, Baxi A, et al. Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr. 2005;82(5):1074–81.CrossRef
21.
go back to reference Yang X, Zhang S. A randomized control study on the clinical effects of ramosetron in prophylaxis of nausea and vomiting induced by cisplatin chemotherapy in patients with lung cancer. Zhongguo fei ai za zhi. 2005;8(4):322–5.PubMed Yang X, Zhang S. A randomized control study on the clinical effects of ramosetron in prophylaxis of nausea and vomiting induced by cisplatin chemotherapy in patients with lung cancer. Zhongguo fei ai za zhi. 2005;8(4):322–5.PubMed
22.
go back to reference Mosa ASM, Hossain AM, Lavoie BJ, Yoo I. Patient-related risk factors for chemotherapy-induced nausea and vomiting: a systematic review. Front Pharm. 2020;11:329.CrossRef Mosa ASM, Hossain AM, Lavoie BJ, Yoo I. Patient-related risk factors for chemotherapy-induced nausea and vomiting: a systematic review. Front Pharm. 2020;11:329.CrossRef
23.
go back to reference Clemons M, Bouganim N, Smith S, Mazzarello S, Vandermeer L, Segal R, et al. Risk model-guided antiemetic prophylaxis vs physician’s choice in patients receiving chemotherapy for early-stage breast cancer: a randomized clinical trial. JAMA Oncol. 2016;2(2):225–31.CrossRef Clemons M, Bouganim N, Smith S, Mazzarello S, Vandermeer L, Segal R, et al. Risk model-guided antiemetic prophylaxis vs physician’s choice in patients receiving chemotherapy for early-stage breast cancer: a randomized clinical trial. JAMA Oncol. 2016;2(2):225–31.CrossRef
24.
go back to reference Xie J, Chen LH, Ning ZY, Zhang CY, Chen H, Chen Z, et al. Effect of transcutaneous electrical acupoint stimulation combined with palonosetron on chemotherapy-induced nausea and vomiting: a single-blind, randomized, controlled trial. Chin J Cancer. 2017;36(1):6.CrossRef Xie J, Chen LH, Ning ZY, Zhang CY, Chen H, Chen Z, et al. Effect of transcutaneous electrical acupoint stimulation combined with palonosetron on chemotherapy-induced nausea and vomiting: a single-blind, randomized, controlled trial. Chin J Cancer. 2017;36(1):6.CrossRef
25.
go back to reference Shen Y, Liu L, Chiang JS, Meng Z, Garcia MK, Chen Z, et al. Randomized, placebo-controlled trial of K1 acupoint acustimulation to prevent cisplatin-induced or oxaliplatin-induced nausea. Cancer. 2015;121(1):84–92.CrossRef Shen Y, Liu L, Chiang JS, Meng Z, Garcia MK, Chen Z, et al. Randomized, placebo-controlled trial of K1 acupoint acustimulation to prevent cisplatin-induced or oxaliplatin-induced nausea. Cancer. 2015;121(1):84–92.CrossRef
26.
go back to reference Zhang X, Fan YH. Effects of electroacupuncture on chemotherapy-induced nausea and vomiting and its mechanism. Zhongguo zhen jiu. 2014;34(11):1061–4.PubMed Zhang X, Fan YH. Effects of electroacupuncture on chemotherapy-induced nausea and vomiting and its mechanism. Zhongguo zhen jiu. 2014;34(11):1061–4.PubMed
27.
go back to reference Baek JY, Trinh TA, Huh W, Song JH, Kim HY, Lim J, et al. Electro-acupuncture alleviates cisplatin-induced anorexia in rats by modulating ghrelin and monoamine neurotransmitters. Biomolecules. 2019;9(10):624.CrossRef Baek JY, Trinh TA, Huh W, Song JH, Kim HY, Lim J, et al. Electro-acupuncture alleviates cisplatin-induced anorexia in rats by modulating ghrelin and monoamine neurotransmitters. Biomolecules. 2019;9(10):624.CrossRef
28.
go back to reference Cui Y, Wang L, Shi G, Liu L, Pei P, Guo J. Electroacupuncture alleviates cisplatin-induced nausea in rats. Acupunct Med. 2016;34(2):120–6.CrossRef Cui Y, Wang L, Shi G, Liu L, Pei P, Guo J. Electroacupuncture alleviates cisplatin-induced nausea in rats. Acupunct Med. 2016;34(2):120–6.CrossRef
29.
go back to reference Kong J, Kaptchuk TJ, Polich G, Kirsch I, Vangel M, Zyloney C, et al. Expectancy and treatment interactions: a dissociation between acupuncture analgesia and expectancy evoked placebo analgesia. NeuroImage. 2009;45(3):940–9.CrossRef Kong J, Kaptchuk TJ, Polich G, Kirsch I, Vangel M, Zyloney C, et al. Expectancy and treatment interactions: a dissociation between acupuncture analgesia and expectancy evoked placebo analgesia. NeuroImage. 2009;45(3):940–9.CrossRef
Metadata
Title
Efficacy of acupuncture in the prevention and treatment of chemotherapy-induced nausea and vomiting in patients with advanced cancer: a multi-center, single-blind, randomized, sham-controlled clinical research
Authors
Qi-Wei Li
Ming-Wei Yu
Xiao-Min Wang
Guo-Wang Yang
Huan Wang
Chen-Xi Zhang
Na Xue
Wei-Ru Xu
Yi Zhang
Pei-Yu Cheng
Lin Yang
Qi Fu
Zhong Yang
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Chinese Medicine / Issue 1/2020
Electronic ISSN: 1749-8546
DOI
https://doi.org/10.1186/s13020-020-00333-x

Other articles of this Issue 1/2020

Chinese Medicine 1/2020 Go to the issue